Howard University Hospital
Washington, District of Columbia, United States
Hospital in Washington, D.C.
2041 Georgia Ave NW, Washington, DC 20060
300 Beds
About Howard University Hospital
Howard University Hospital, previously known as Freedmen's Hospital, is a major hospital located in Washington, D.C., built on the site of the previous Griffith Stadium.
There are 300 beds in Howard University Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Howard University Hospital
During the past decade, Howard University Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 13 clinical trials were completed, i.e. on
average, 130% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)
2011-12-01
2018-12-14
Completed
51
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
2016-09-01
2023-08-01
Active, not recruiting
539
A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
2020-10-12
2025-06-30
Recruiting
31
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)
2021-05-26
2025-06-01
Active, not recruiting
212
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
2021-05-27
2026-05-23
Recruiting
440
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
2021-02-25
2025-08-23
Recruiting
309
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2022-06-23
2033-01-26
Recruiting
864
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Howard University Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 27 trials, followed by "National Cancer Institute (NCI)" with 8 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Georgetown University" with 3 trials sponsored and "National Heart, Lung, and Blood Institute (NHLBI)"
with 3 trials sponsored. Other sponsors include 45 different institutions and
companies that sponsored additional 42 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Howard University Hospital"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 15 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Glaxo Wellcome" with 5 trials as a collaborator and "Howard University" with 5 trials as a collaborator. Other collaborators include 45 different institutions and companies that were
collaborators in the rest 47 trials.
Clinical Trials Conditions at Howard University Hospital
According to Clinical.Site data, the most researched conditions in "Howard University Hospital" are
"HIV Infections" (29 trials), "Sickle Cell Disease" (13 trials), "Pregnancy" (7 trials), "Prostate Cancer" (5 trials) and "Pulmonary Hypertension" (4 trials). Many other conditions were trialed in "Howard University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Howard University Hospital
Most popular intervention types in "Howard University Hospital" are "Drug" (57 trials), "Other" (17 trials), "Biological" (10 trials), "Behavioral" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (11 trials), "Placebo" (10 trials), "Didanosine" (7 trials), "Lamivudine" (6 trials) and "Nevirapine" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Howard University Hospital
The vast majority of trials in "Howard University Hospital" are
83 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Howard University Hospital
Currently, there are NaN active trials in "Howard University Hospital".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 74 completed trials in Howard University Hospital,
undefined suspended trials,
and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Howard University Hospital, 10 "Phase 1"
clinical trials were conducted, 24 "Phase 2" clinical
trials and 27 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 13 trials that are defined as “Not Applicable".